AB

AbClon Inc.

Develops antibody therapeutics and CAR-T for oncology and provides CRO services.

174900 | KO

Overview

Corporate Details

ISIN(s):
KR7174900001
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 285 에이스트윈타워 1차 1401호, 구로구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

AbClon Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel antibody-based therapeutics, primarily for oncology. The company's core technological assets include the CAR-T platform for personalized cancer immunotherapies, the NEST (Novel Epitope Screening Technology) platform for discovering antibodies against unique epitopes on disease proteins, and the AffiMab platform for the agile development of bispecific antibodies. These platforms are designed to address refractory diseases by creating treatments with novel therapeutic effects. In addition to its therapeutic pipeline, AbClon provides contract research organization (CRO) services, including antibody production and purification.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.3 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-11 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.5 KB
2025-07-14 00:00
Share Issue/Capital Change
전환주식의전환가액조정 (전환우선주)
Korean 11.3 KB
2025-05-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 79.7 KB
2025-05-21 00:00
M&A Activity
[기재정정]투자판단관련주요경영사항 (CART 세포치료제 `AT101` 기술이전 계약 체결)
Korean 18.3 KB
2025-05-20 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.3 KB
2025-05-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.1 KB
2025-05-19 00:00
Share Issue/Capital Change
전환주식의전환가액조정
Korean 12.0 KB
2025-05-15 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 895.6 KB
2025-05-09 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 42.1 KB
2025-05-09 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 45.1 KB
2025-04-28 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 29.9 KB
2025-04-28 00:00
Audit Report / Information
[기재정정]사업보고서 (2023.12)
Korean 522.3 KB

Automate Your Workflow. Get a real-time feed of all AbClon Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbClon Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AbClon Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Resolute Holdings Management, Inc. Logo
Asset management firm acquiring and operationally enhancing companies for long-term growth.
United States of America
RHLD
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan
4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan
9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
ROSS GROUP PLC Logo
A holding company in liquidation, formerly providing supply chain management & technology solutions.
United Kingdom
RGP
ROXX, Inc. Logo
HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.
Japan
241A
SAFTEC CO.,LTD. Logo
Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.
Japan
7464
Salarius Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.
United States of America
SLRX
Saniona Logo
Develops ion channel medicines for rare neurological diseases and epilepsy.
Denmark
SANION
Santech Holdings Ltd Logo
A technology company developing innovative consumer and enterprise technology businesses.
United States of America
STEC

Talk to a Data Expert

Have a question? We'll get back to you promptly.